Certification programs provide independent analysis of supplement products for athletes, military members, and other drug-tested professionals, reducing, but not eliminating, the risk of unintentional banned substance exposure
For chronic weight management, both trizepatide (Zepbound) and semaglutide 2.4 mg (Wegovy) are indicated for adults with a BMI 30 or a BMI 27 with at least one weight-related condition (such as hypertension, dyslipidemia, type 2 diabetes, sleep apnea, or cardiovascular disease)
Semaglutide Semaglutide is a GLP-1 receptor agonist designed to support weight management and blood sugar control
Other frequent side effects include: Stomach pain (6-7% of patients) Constipation (3-7% of patients) Serious but rare side effects of Ozempic include inflammation of the pancreas (pancreatitis), changes in vision, and kidney problems